Abstract
The 2006 American Heart Association guidelines for management of patients with atrial fibrillation state “For patients with no identifiable thrombus in the left atrium (LA) or left atrial appendage (LAA), cardioversion (CV) is reasonable immediately after anticoagulation with unfractionated heparin. Thereafter, continuation of oral anticoagulation is reasonable for an anticoagulation period of at least 4 weeks”. For patients with thrombus identified by transesophageal echocardiography, guidelines recommend therapeutic oral anticoagulation for 3 weeks prior to and 4 weeks after elective cardioversion.
Patients with spontaneous echo contrast (SEC) identified by TEE have a high risk of thromboembolic events,1, 2, 3, 4, 5, 6, 7, 8 however, the guidelines do not address whether patients with SEC without thrombus can be safely cardioverted. This paper reviews the literature describing the pathogenesis of SEC, how it is detected, and whether elective cardioversion is safe.
On the basis of our review, we believe that the risk of cardioembolic stroke after cardioversion of a patient with SEC is low, regardless of anticoagulation. The safe conclusion is that patients with SEC on TEE should receive therapeutic anticoagulation prior to cardioversion if possible and early cardioversion is not contraindicated. Copyright © 2008 Wiley Periodicals, Inc.
Keywords: cardioversion, spontaneous echo contrast, atrial fibrillation, transesophageal echocardiography
Full Text
The Full Text of this article is available as a PDF (96.9 KB).
REFERENCES
- 1. Fatkin D, Herbert E, Feneley MP: Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994; 73(9): 672–676. [DOI] [PubMed] [Google Scholar]
- 2. Black IW: Spontaneous echo contrast: where there's smoke there's fire. Echocardiography 2000; 17(4): 373–382. [DOI] [PubMed] [Google Scholar]
- 3. Fatkin D, Kelly RP, Feneley MP: Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. JACC 1994; 23(4): 961–969. [DOI] [PubMed] [Google Scholar]
- 4. Ansari A, Maron BJ: Spontaneous echo contrast and thromboembolism. Hosp Pract 1997; 32(1): 109–111. [DOI] [PubMed] [Google Scholar]
- 5. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H: Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow‐up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. JACC 2005; 45(11): 1807–1812. [DOI] [PubMed] [Google Scholar]
- 6. Kamensky G, Drahos P, Plevova N: Left atrial spontaneous echo contrast: its prevalence and importance in patients undergoing transesophageal echocardiography and particularly those with a cerebrovascular embolic event. J Am Soc Echocardiogr 1996; 9(1): 62–70. [DOI] [PubMed] [Google Scholar]
- 7. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, et al.: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1998; 31(7): 1622–1626. [DOI] [PubMed] [Google Scholar]
- 8. Asinger RW, Koehler J, Pearce LA, Zabalgoitia M, Blackshear JL, et al.: Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. J Am Soc Echocardiogr 1999; 12(12): 1088–1096. [DOI] [PubMed] [Google Scholar]
- 9. Turchetti V, Bellini MA, Ricci D, Lapi A, Donati G, et al.: Spontaneous echo‐contrast as an in vivo indicator of rheological imbalance in dilatative cardiomyopathy. Clin Hemorheol Microcirc 2001; 25(3–4): 119–125. [PubMed] [Google Scholar]
- 10. Lip GY: Hypercoagulability and haemodynamic abnormalities in atrial fibrillation. Heart 1997; 77(5): 407–411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Zotz RJ, M&uller M, Genth‐Zotz S, Darius H: Spontaneous echo contrast caused by platelet and leukocyte aggregates? Stroke 2001; 32: 1127–1133. [DOI] [PubMed] [Google Scholar]
- 12. Soncini M, Casazza F, Mattioli R, Bonfardeci C, Motta A, et al.: Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation. Minerva Med 1997; 88(12): 501–505. [PubMed] [Google Scholar]
- 13. Ito T, Suwa M, Nakamura T, Miyazaki S, Kpbashi A, et al.: Quantification of left atrial appendage spontaneous echo contrast in patients with chronic nonalvular atrial fibrillation. J Cardiol 2001; 37(6): 325–333. [PubMed] [Google Scholar]
- 14. Kwaan HC, Sakurai S, Wang J: Rheological abnormalities and thromboembolic complications in heart disease: spontaneous echo contrast and red cell aggregation. Semin Thromb Hemost 2003; 29(5): 529–534. [DOI] [PubMed] [Google Scholar]
- 15. Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, et al.: Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. J Am Soc Echocardiogr 1999; 12(12): 1080–1087. [DOI] [PubMed] [Google Scholar]
- 16. Tsai LM, Chao TH, Chen JH: Association of follow‐up change of left atrial appendage blood flow velocity with spontaneous echo contrast in nonrheumatic atrial fibrillation. Chest 2000; 117(2): 309–313. [DOI] [PubMed] [Google Scholar]
- 17. Ito T, Suwa M, Nakamura T, Miyazaki S, Hirota Y, et al.: Influence of warfarin therapy on left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. Am J Cardiol 1999; 84(7): 857–859. [DOI] [PubMed] [Google Scholar]
- 18. Zabalgoita M, Leonard A, Blackshear JL, Safford R, Baker VS, et al.: The stroke prevention in atrial fibrillation investigators committee on echocardiography: transesophageal echocardiographic correlates of thromboembolism in high‐risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639–647. [DOI] [PubMed] [Google Scholar]
- 19. Khan IA: Atrial stunning: basics and clinical considerations. Int J Cardiol 2003; 92: 113–128. [DOI] [PubMed] [Google Scholar]
- 20. Dagres N, Karatasakis G, Panou F, Athanassopoulos G, Maounis T, et al.: Pre‐treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation. Eur Heart J 2006; 27(17): 2062–2068. [DOI] [PubMed] [Google Scholar]
- 21. Klein AL, Grimm RA, Murray RD, Apperson‐Hansen C, Stat M, et al.: Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. ACUTE Trial. N Engl J Med 2001; 344(19): 1411–1420. [DOI] [PubMed] [Google Scholar]
- 22. Black IW, Fatkin D, Sagar KB, Khandheri BK, Leung DY, et al.: Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. Circulation 1994; 89: 2509–2513. [DOI] [PubMed] [Google Scholar]
- 23. Asher CR, Klein AL: Transesophageal echocardiography in patients with atrial fibrillation. Pacing Clin Electrophysiol 2003; 26: 1597–1603. [DOI] [PubMed] [Google Scholar]
- 24. Manning WJ, Silverman DI, Gordon S, Harlan M, Douglas PS: Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993; 328: 750–755. [DOI] [PubMed] [Google Scholar]
- 25. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS: Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short‐term anticoagulation: final results of a prospective 4.5‐year study. JACC 1995; 25: 1354–1361. [DOI] [PubMed] [Google Scholar]
- 26. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, et al.: Accuracy of transesophageal echocardiography for identifying left atrial thrombi. Ann Intern Med 1995; 123: 817–822. [DOI] [PubMed] [Google Scholar]
- 27. Fatkin D, Scalia G, Jacobs N, Burstow D, Leung D, et al.: Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol 1996; 77: 321–323. [DOI] [PubMed] [Google Scholar]
- 28. Stoddard MF, Dawkins PR, Prince CR, Longaker RA: Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995; 129(6): 1204–1215. [DOI] [PubMed] [Google Scholar]
- 29. Orsinelli DA, Pearson AC: Usefulness of transesophageal echocardiography to screen for left atrial thrombus before elective cardioversion for atrial fibrillation. Am J Cardiol 1993; 72(17): 1337–1339. [DOI] [PubMed] [Google Scholar]
- 30. Corrado G, Santarone M, Beretta S, Tadeo G, Tagliagambe LM, et al.: Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography. Europace 2000; 2(2): 119–126. [DOI] [PubMed] [Google Scholar]
- 31. Klein AL, Grimm RA, Black IW, Leung DY, Chung MK, et al.: Cardioversion guided by transesophageal echocardiography: The ACUTE Pilot Study. Ann Intern Med 1997; 126(3): 200–209. [DOI] [PubMed] [Google Scholar]
- 32. Maltagliati A, Galli CA, Tamborini G, Calligaris A, Doria E, et al.: Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens. Heart 2006; 92(7): 933–938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Strandberg M, Raatikainen MJ, Niemela M, Luotolahti M, Hartiala J, et al.: Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation. Europace. 2006; 8(6): 408–412. [DOI] [PubMed] [Google Scholar]
- 34. Roijer A, Eskilsson J, Olsson B: Transoesophageal echocardiography‐guided cardioversion of atrial fibrillation or flutter. Eur Heart J 2000; 21(10): 837–847. [DOI] [PubMed] [Google Scholar]
- 35. Fonseca N, Caetano F, Santos J, Seixo F, Bernardino L, et al.: Transesophageal echocardiography‐guided cardioversion of atrial fibrillation. Rev Port Cardiol 2004; 23(3): 365–375. [PubMed] [Google Scholar]